Weakening Impact of Excessive Human Serum Albumin (eHSA) on Cisplatin and Etoposide Anticancer Effect in C57BL/6 Mice with Tumor and in Human NSCLC A549 Cells

Excessive human serum albumin (eHSA) impact on anticancer effects is inconsistent. We explored the outcome of cisplatin (DDP)/etoposide (VP-16) plus eHSA in vivo and in vitro. C57BL/6 mice with tumor were used to compare the efficacy of DDP/VP-16 alone and DDP/VP-16+eHSA. Blood albumin was measured...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Zhen, Zhou, Ting, Cheng, Yuanchi, Li, Mingming, Tan, Xianglin, Xu, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5108922/
https://www.ncbi.nlm.nih.gov/pubmed/27895586
http://dx.doi.org/10.3389/fphar.2016.00434

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5108922/
https://www.ncbi.nlm.nih.gov/pubmed/27895586
http://dx.doi.org/10.3389/fphar.2016.00434

Ejemplares similares